Strensiq (Alexion Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Strensiq drug offered from Alexion Pharmaceuticals Inc.. This Tissue-nonspecific Alkaline Phosphatase [EPC],Alkaline Phosphatase [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alexion Pharmaceuticals Inc.
NON-PROPRIETARY NAME: asfotase alfa
SUBSTANCE NAME: ASFOTASE ALFA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Tissue-nonspecific Alkaline Phosphatase [EPC],Alkaline Phosphatase [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2015-10-23
END MARKETING DATE: 0000-00-00


Strensiq HUMAN PRESCRIPTION DRUG Details:

Item DescriptionStrensiq from Alexion Pharmaceuticals Inc.
LABELER NAME: Alexion Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 18(mg/.45mL)
START MARKETING DATE: 2015-10-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25682-010_82e667d9-dbd1-40df-8a25-10f6e3e58c82
PRODUCT NDC: 25682-010
APPLICATION NUMBER: BLA125513

Other ASFOTASE ALFA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alexion Pharmaceuticals Inc.Strensiq